Implantable cardioverter-defibrillators (ICDs) include antitachycardia pacing (ATP) and high-
energy shocks (HES) for terminating ventricular tachyarrhythmias. ATP effectively terminates …

Aims Little is known about the optimal number of antitachycardia pacing (ATP) attempts to
programme in the fast ventricular tachycardia (FVT) zone. We sought to analyse the long …

Introduction and objectives Fast ventricular tachycardias in the ventricular fibrillation zone in
patients with an implantable cardioverter-defibrillator are susceptible to antitachycardia …

To the Editor: Between 11% and 40% of detected monomorphic ventricular tachycardias
(VTs) in patients with implantable cardioverter-defibrillators (ICDs) have a cycle length (CL) …

Background Antitachycardia pacing (ATP) is routinely used to terminate ventricular
tachyarrhythmias (VTs). However, little guidance exists on the most effective programming of …

Patients with an implantable cardioverter defibrillator (ICD) can undergo inappropriate
therapies if electrical activity not originating in the ventricle is wrongly recognized as …

Background Anti‐tachycardia pacing (ATP) delivered from an implantable device is an
important tool to terminate ventricular tachycardia (VT). But its real‐world efficacy for fast VT …

Background Antitachycardia pacing (ATP) is an effective treatment for ventricular
tachycardia (VT). We evaluated the efficacy of different ATP programs based on a large …

Ventricular tachycardia storm (VTS) is defined as a life-threatening syndrome of three or
more separate episodes of ventricular tachycardia (VT) leading to implantable cardioverter …

Abstract Funding Acknowledgements Medtronic OnBehalf PainFree SST Background Anti-
tachycardia Pacing (ATP) is an established therapy that terminates VT without the need for …